Arbutus Biopharma Corporation (ABUS) Buy or Sell Stock Guide

Last updated: Jul 12, '19

Are you looking for the analysis of Arbutus Biopharma Corporation (ABUS) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 3 reasons to buy and 2 reasons to sell ABUS stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about ABUS stock:

  • Is ABUS a buy or a sell?
  • Should I sell or hold ABUS stock today?
  • Is ABUS a good buy / investment?
  • What are ABUS analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy ABUS stock:

1. ABUS forward P/E ratio is 9.97, and it’s low compared to its industry peers’ P/E ratios. See ABUS forward P/E ratio chart.

2. ABUS average analyst rating is Buy. See ABUS analyst rating chart.

3. ABUS average analyst price target ($4.75) is above its current price ($2.35). See ABUS price target chart.

Now that you understand the bull case, let’s look at the reasons to sell ABUS stock (i.e., the bear case):

1. ABUS profitability is declining. The YoY profit margin change was -332.12percentage points. See ABUS profitability chart.

2. ABUS short share of float is 5.17%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See ABUS short share of float chart.

Now let's look at the key statistics for ABUS:

Metrics ABUS
Price $1.96
Average Price Target / Upside $4.75 / 142.97%
Average Analyst Rating Buy
Industry Biotechnology
Sector Healthcare
Number of Employees 80
Market Cap $121.83M
Forward P/E Ratio 9.9701
Price/Book Ratio 22.4536
PEG N/A
Revenue (TTM) $5.19M
YoY Quarterly Revenue Growth N/A
Profit Margin -1413.2947976878609%

What are your thoughts on ABUS?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Comments (0)expand_more